Dependence Potential of the Synthetic Cannabinoids JWH-073, JWH-081, and JWH-210: In Vivo and In Vitro Approaches |
Cha, Hye Jin
(Pharmacological Research Division, Toxicological Evaluation and Research Department, National Institute of Food and Drug Safety Evaluation, Ministry of Food and Drug Safety)
Lee, Kwang-Wook (Pharmacological Research Division, Toxicological Evaluation and Research Department, National Institute of Food and Drug Safety Evaluation, Ministry of Food and Drug Safety) Song, Min-Ji (Pharmacological Research Division, Toxicological Evaluation and Research Department, National Institute of Food and Drug Safety Evaluation, Ministry of Food and Drug Safety) Hyeon, Yang-Jin (Pharmacological Research Division, Toxicological Evaluation and Research Department, National Institute of Food and Drug Safety Evaluation, Ministry of Food and Drug Safety) Hwang, Ji-Young (School of Pharmacy, Sungkyunkwan University) Jang, Choon-Gon (School of Pharmacy, Sungkyunkwan University) Ahn, Joon-Ik (Pharmacological Research Division, Toxicological Evaluation and Research Department, National Institute of Food and Drug Safety Evaluation, Ministry of Food and Drug Safety) Jeon, Seol-Hee (Pharmacological Research Division, Toxicological Evaluation and Research Department, National Institute of Food and Drug Safety Evaluation, Ministry of Food and Drug Safety) Kim, Hyun-Uk (Pharmacological Research Division, Toxicological Evaluation and Research Department, National Institute of Food and Drug Safety Evaluation, Ministry of Food and Drug Safety) Kim, Young-Hoon (Pharmacological Research Division, Toxicological Evaluation and Research Department, National Institute of Food and Drug Safety Evaluation, Ministry of Food and Drug Safety) Seong, Won-Keun (Pharmacological Research Division, Toxicological Evaluation and Research Department, National Institute of Food and Drug Safety Evaluation, Ministry of Food and Drug Safety) Kang, Hoil (Pharmacological Research Division, Toxicological Evaluation and Research Department, National Institute of Food and Drug Safety Evaluation, Ministry of Food and Drug Safety) Yoo, Han Sang (Department of Infectious Diseases, College of Veterinary Medicine, Seoul National University) Jeong, Ho-Sang (Pharmacological Research Division, Toxicological Evaluation and Research Department, National Institute of Food and Drug Safety Evaluation, Ministry of Food and Drug Safety) |
1 | Alexander, S. P., Mathie, A. and Peters, J. A. (2008) Guide to receptors and channels (GRAC). Br. J. Pharmacol. 153, S1-209. DOI ScienceOn |
2 | Atwood, B. K., Lee, D., Straiker, A., Widlanski, T. S. and Mackie, K. (2011) CP47, 497-C8 and JWH073, commonly found in 'Spice' herbal blends, are potent and efficacious CB1 cannabinoid receptor agonists. Eur. J. Pharmacol. 659, 139-145. DOI |
3 | Aung, M. M., Griffi n, G., Huffman, J. W., Wu, M. J., Keel, C., Yang, B., Showalter, V. M., Abood, M. E. and Martin, B. R. (2000) Influence of the N-1 alkyl chain length of cannabimimetic indoles upon CB1 and CB2 receptor binding. Drug Alcohol Depend. 60, 133-140. DOI |
4 | Showalter, V. M., Compton, D. R., Martin, B. R. and Abood, M. E. (1996) Evaluation of binding in a transfected cell line expressing a peripheral cannabinoid receptor (CB2): identifi cation of cannabinoid receptor subtype selective ligands. J. Pharmacol. Exp. Ther. 278, 989-999. |
5 | Uchiyama, N., Kikura-Hanajiri, R., Kawahara, N. and Goda, Y. (2009a) Identifi cation of a cannabimimetic indole as a designer drug in a herbal product. Forensic Toxicol. 27, 61-66. DOI |
6 | Uchiyama, N., Kikura-Hanajiri, R., Kawahara, N., Haishima, Y. and Goda, Y. (2009b) Identifi cation of a cannabinoid analog as a new type of designer drug in a herbal product. Chem. Pharm. Bull. 57, 439-441. DOI |
7 | Valjent, E. and Maldonado, R. (2000) A behavioural model to reveal place preference to delta9-tetrahydrocannabinol in mice. Psychopharmacology 147, 436-438. DOI |
8 | Wu, D. F., Yang, L. Q., Goschke, A., Stumm, R., Brandenburg, L. S., Liang, Y. J., Hollt, V. and Koch, T. (2008) Role of receptor internalization in the agonist-induced desensitization of cannabinoid type 1 receptors. J. Neurochem. 104, 1132-1143. DOI |
9 | Zangen, A., Solinas, M., Ikemoto, S., Goldberg, S. R. and Wise, R. A. (2006) Two brain sites for cannabinoid reward. J. Neurosci. 26, 4901-4907. DOI |
10 | Roche, J. P., Bounds, S., Brown, S. and Mackie, K. (1999) A mutation in the second transmembrane region of the CB1 receptor selectively disrupts G protein signaling and prevents receptor internalization. Mol. Pharmacol. 56, 611-618. DOI |
11 | Auwarter, V., Dresen, S., Weinmann, W., Muller, M., Puts, M. and Ferreiros, N. (2009) 'Spice' and other herbal blends: harmless incense or cannabinoid designer drugs? J. Mass Spectrom. 44, 832-837. DOI |
12 | Corcoran, M. E. and Amit, Z. (1974) Reluctance of rats to drink hashish suspensions: free-choice and forced consumption, and the effects of hypothalamic stimulation. Psychopharmacologia 35, 129-147. DOI |
13 | Bozarth, M. A. (1987) Conditioned place preference: A parametric analysis using systemic heroin injections. In: Methods of assessing the reinforcing properties of abused drugs. (M. A. Bozarth, Ed), pp 241-273. Springer-Verlag, New York. |
14 | Carlezon, W. A. and Chartoff, E. H. (2007) Intracranial self-stimulation (ICSS) in rodents to study the neurobiology of motivation. Nat. Protoc. 2, 2987-2995. DOI ScienceOn |
15 | Chaperon, F. and Thiebot, M. H. (1999) Behavioral effects of cannabinoid agents in animals. Crit. Rev. Neurobiol. 13, 243-281. DOI |
16 | Devane, W. A., Dysarz, F. A. 3rd, Johnson, M. R., Melvin, L. S. and Howlett, A. C. (1988) Determination and characterization of a cannabinoid receptor in rat brain. Mol. Pharmacol. 34, 605-613. |
17 | Gaoni, Y. and Mechoulam, R. (1964) Isolation, structure, and partial synthesis of an active constituent of hashish. J. Am. Chem. Soc. 86, 1646-1647. DOI |
18 | ElSohly, M. A., Gul, W., Wanas, A. S. and Radwan, M. M. (2014) Synthetic Cannabinoids: Analysis and Metabolites. Life Sci. 97, 78-90. DOI |
19 | Hsieh, C., Brown, S., Derleth, C. and Mackie, K. (1999) Internalization and recycling of the CB1 cannabinoid receptor. J. Neurochem. 73, 493-501. |
20 | Leite, J. R. and Carlini, E. A. (1974) Failure to obtain 'cannabis-directed behavior' and abstinence syndrome in rats chronically treated with Cannabis sativa extracts. Psychopharmacologia 36, 133-145. DOI |
21 | Jin, W., Brown, S., Roche, J. P., Hsieh, C., Celver, J. P., Kovoor, A., Chavkin, C. and Mackie, K. (1999) Distinct domains of the CB1 cannabinoid receptor mediate desensitization and internalization. J. Neurosci. 19, 3773-3780. |
22 | Mackie, K. (2005) Distribution of cannabinoid receptors in the central and peripheral nervous system. Handb. Exp. Pharmacol. 168, 299-325. DOI |
23 | Mucha, R. F., Van Der Kooy, D., O'Shaughnessy, M. and Bucenieks, P. (1982) Drug reinforcement studied by the use of place conditioning in rat. Brain Res. 243, 91-105. DOI ScienceOn |
24 | Narita, M., Akai, H., Nagumo, Y., Sunagawa, N., Hasebe, K., Nagase, H., Kita, T., Hara, C. and Suzuki, T. (2004) Implications of protein kinase C in the nucleus accumbens in the development of sensitization to methamphetamine in rats. Neuroscience 127, 941-948. DOI ScienceOn |
25 | Van Sickle, M. D., Duncan, M., Kingsley, P. J., Mouihate, A., Urbani, P., Mackie, K., Stella, N., Makriyannis, A., Piomelli, D. and Davison, J. S. (2005) Identifi cation and functional characterization of brainstem cannabinoid CB2 receptors. Science 310, 329-332. DOI |